Senior Executive Assistant

Susan Martin serves as Senior Executive Assistant for Avenzo Therapeutics, responsible for supporting the daily activities for the Chief Executive Officer. She has more than 20 years of experience supporting C-suite executives and contributing to the success of organizations undergoing significant transformations, from mergers and acquisitions to high-stakes IPOs.

Ms. Martin recently served as Executive Assistant for Turning Point Therapeutics, which was acquired by Bristol Myers Squibb in August 2022. Prior to Turning Point, she supported the Chief Executive Officer of Ignyta, which was acquired by Roche in 2017.